Last reviewed · How we verify

oleum neutralicum — Competitive Intelligence Brief

oleum neutralicum (oleum neutralicum) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Unknown; possibly vitamin D analog or immunomodulator. Area: Oncology.

discontinued Unknown; possibly vitamin D analog or immunomodulator Unknown; possibly vitamin D receptor (VDR) if vitamin D3-based Oncology Small molecule Live · refreshed every 30 min

Target snapshot

oleum neutralicum (oleum neutralicum) — Semmelweis University. Mechanism of action unknown; product appears to be a vitamin D3 formulation studied in hematologic malignancies.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
oleum neutralicum TARGET oleum neutralicum Semmelweis University discontinued Unknown; possibly vitamin D analog or immunomodulator Unknown; possibly vitamin D receptor (VDR) if vitamin D3-based

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Unknown; possibly vitamin D analog or immunomodulator class)

  1. Semmelweis University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). oleum neutralicum — Competitive Intelligence Brief. https://druglandscape.com/ci/oleum-neutralicum. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: